Business Today | Zydus receives marketing exclusivity approval for Sirolimus tablets Business Standard The Ahmedabad-based Zydus Cadila received the final approval from the US FDA to market Sirolimus tablets 0.5 mg with 180 days of marketing exclusivity. As per IMS data in 2013, the sales of Sirolimus 0.5 mg was estimated at $11.7 million and the total ... Zydus gets US FDA nod for Sirolimus tablets, Duloxetine capsules Zydus Cadila gets USFDA approval to sell medicine which prevents rejection in ... Zydus Cadila gets USFDA nod to sell drugs in the US market |
